Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q4 2016
|
GNCA |
|
Phase 2b Results |
Infectious Disease |
None |
|
H2 2016
|
ADHD |
|
Phase 3 Results |
Neurology |
None |
|
Q4 2016
|
ACOR |
|
Phase 3 Results |
Neurology |
None |
|
H2 2016
|
ALKS |
|
sNDA Submission |
Other |
None |
|
H2 2016
|
ARRY |
|
Phase 3 Results |
Oncology |
Orphan Drug |
|
H2 2016
|
CHRS |
|
Phase 3 Results |
Other |
None |
|
H2 2016
|
CRMD |
|
Phase 3 Results |
Other |
Fast Track |
|
Q4 2016
|
GWPH |
|
NDA Submission |
Neurology |
Fast Track, Orphan Drug |
|
H2 2016
|
HZNP |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
Q4 2016
|
ITEK |
|
Phase 3 Results |
Opthamology |
None |
|